14
|
Chang AJ, McBride S, Keyes M, Chung HT, Davis BJ, Cox BW, Crook J, Demanes DJ, Hsu IC, Kamrava M, Krauss DJ, Morton G, Orio Iii PF, Roach Iii M, Venkat PS, Vigneault E, Zelefsky MJ. The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee Endorse the American Society of Clinical Oncology/Cancer Care Ontario Guidelines. J Clin Oncol 2018; 36:JCO1800626. [PMID: 30212298 DOI: 10.1200/jco.18.00626] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/28/2024] Open
Affiliation(s)
- Albert J Chang
- Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY
| | - Sean McBride
- Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY
| | - Mira Keyes
- Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY
| | - Hans T Chung
- Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY
| | - Brian J Davis
- Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY
| | - Brett W Cox
- Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY
| | - Juanita Crook
- Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY
| | - David J Demanes
- Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY
| | - I Chow Hsu
- Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY
| | - Mitchell Kamrava
- Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY
| | - Daniel J Krauss
- Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY
| | - Gerard Morton
- Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY
| | - Peter F Orio Iii
- Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY
| | - Mack Roach Iii
- Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY
| | - Puja S Venkat
- Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY
| | - Eric Vigneault
- Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY
| | - Michael J Zelefsky
- Albert J. Chang, University of California, Los Angeles, Los Angeles, CA; Sean McBride, Memorial Sloan Kettering Cancer Center, New York, NY; Mira Keyes, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Colombia, Canada; Hans T. Chung, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Brian J. Davis, Mayo Clinic, Rochester, MN; Brett W. Cox, Northwell Health and Hofstra Northwell School of Medicine, New York, NY; Juanita Crook, British Columbia Cancer Agency, Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada; David J. Demanes, University of California, Los Angeles, Los Angeles, CA; I. Chow Hsu, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Mitchell Kamrava, Cedars Sinai Medical Center, Los Angeles, CA; Daniel J. Krauss, Beaumont Health System, Royal Oak, MI; Gerard Morton, University of Toronto and Odette Cancer Centre, Toronto, Ontario, Canada; Peter F. Orio III, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Mack Roach III, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Puja S. Venkat, University of California, Los Angeles, Los Angeles, CA; Eric Vigneault, Centre de Recherche sur le Cancer, CHU de Québec, Université Laval, Québec, Canada; and Michael J. Zelefsky, Memorial Sloan Kettering Cancer Center, New York, NY
| |
Collapse
|